Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Evaluate PK Profile”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Early research (Phase 1)Study completedNCT03610867
What this trial is testing

To Evaluate the Safety, Tolerability, and Pharmacokinetics Profile in Healthy Chinese Volunteers of TG-2349

Who this might be right for
Healthy Chinese Volunteers
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 64
Early research (Phase 1)Looking for participantsNCT07422610
What this trial is testing

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

Who this might be right for
Advanced Malignancies and Hepatic Impairment
Novartis Pharmaceuticals 24
Early research (Phase 1)UnknownNCT05863442
What this trial is testing

Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants

Who this might be right for
Healthy
Turgut Ardika PTY LTD 120
Testing effectiveness (Phase 2)Study completedNCT06973681
What this trial is testing

BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

Who this might be right for
Overweight or Obesity
BrightGene Bio-Medical Technology Co., Ltd. 120
Early research (Phase 1)Study completedNCT04120233
What this trial is testing

MW151-101: First-in-human Study of MW151

Who this might be right for
Drug Toxicity
Linda Van Eldik 40
Not applicableStudy completedNCT01983839
What this trial is testing

PK Analysis of Moxifloxacin in the Treatment of CAP

Who this might be right for
Pneumonia
University of Aarhus 18
Early research (Phase 1)UnknownNCT04862884
What this trial is testing

A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects

Who this might be right for
Pain
Jiangsu HengRui Medicine Co., Ltd. 50
Early research (Phase 1)Study completedNCT03714685
What this trial is testing

Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations

Who this might be right for
Healthy Males
Quantum Genomics SA 12
Early research (Phase 1)Not Yet RecruitingNCT07462455
What this trial is testing

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Xiamen Amoytop Biotech Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT05118958
What this trial is testing

Phase 1 Crossover Study in Healthy Subjects to Evaluate the PK Profile of KVD824 Following Single and Multiple Doses of Modified Release (MR) Formulations

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 37
Early research (Phase 1)UnknownNCT03770624
What this trial is testing

Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA

Who this might be right for
Chronic Hepatitis b
Qilu Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Study completedNCT01800305
What this trial is testing

PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual

Who this might be right for
Healthy
Xiamen Amoytop Biotech Co., Ltd. 150
Post-approval studies (Phase 4)Study completedNCT00744679
What this trial is testing

A Pharmacokinetic (PK) Study of Natalizumab (Tysabri) at Steady State

Who this might be right for
Multiple Sclerosis
Biogen 20
Early research (Phase 1)Study completedNCT00255996
What this trial is testing

Evaluation Of Linezolid Pk Profile In Burns Patients

Who this might be right for
Burns
Pfizer 16
Early research (Phase 1)Study completedNCT02173808
What this trial is testing

A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception

Who this might be right for
Contraceptive Usage
Premier Research 16
Early research (Phase 1)Study completedNCT03424252
What this trial is testing

Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects

Who this might be right for
Cystic Fibrosis
Flatley Discovery Lab LLC 11
Early research (Phase 1)Study completedNCT00698464
What this trial is testing

Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function

Who this might be right for
Hepatic CirrhosisAlcoholism
Novartis Pharmaceuticals 34
Early research (Phase 1)Study completedNCT01992211
What this trial is testing

Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin

Who this might be right for
Healthy
BC World Pharm Co. Ltd. 35
Early research (Phase 1)Study completedNCT03650075
What this trial is testing

To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Metagone Biotech Inc. 81
Next Page